Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Cabaletta Bio, Inc. (CABA)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 51,420,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Co.'s proprietary technology utilizes Chimeric AutoAntibody Receptor, T cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Co.'s main CAAR T cell product candidate was designed based on the Chimeric Antigen Receptor, T cell technology that is marketed for the treatment of B cell cancers. Co.'s initial focus is mucosal pemphigus vulgaris, which is an autoimmune blistering disease.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 346,000
Total Buy Value $0 $0 $0 $343,789
Total People Bought 0 0 0 5
Total Buy Transactions 0 0 0 7
Total Shares Sold 0 33,000 110,000 110,000
Total Sell Value $0 $652,242 $1,694,746 $1,694,746
Total People Sold 0 1 1 1
Total Sell Transactions 0 3 9 9
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 40
  Page 2 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Nichtberger Steven President & CEO   •       •      –    2022-01-31 4 OE $1.01 $50,500 D/D 50,000 836,483     -
   Schwab Andrew J. 10% Owner   –       –       •   2021-11-01 4 S $13.00 $3,835,000 I/I (295,000) 333,144     -
   Schwab Andrew J. 10% Owner   –       –       •   2021-09-07 4 S $9.70 $6,062,500 I/I (625,000) 1,989,575     -
   Schwab Andrew J. 10% Owner   –       –       •   2021-01-12 4 S $13.00 $1,105,000 I/I (85,000) 369,688     -
   Schwab Andrew J. 10% Owner   –       –       •   2021-01-08 4 S $13.00 $3,926,000 I/I (302,000) 380,218     -
   Schwab Andrew J. 10% Owner   –       –       •   2020-12-10 4 S $14.75 $4,395,500 I/I (298,000) 417,629     -
   Schwab Andrew J. 10% Owner   –       –       •   2019-10-29 4 B $11.00 $4,999,995 I/I 454,545 454,545 1.5     -
   Schwab Andrew J. 10% Owner   –       –       •   2019-10-29 4 A $0.00 $0 I/I 3,214,721 3,214,721     -
   Nichtberger Steven President & CEO   •       •      –    2019-10-29 4 A $0.00 $0 D/D 60,483 786,483     -
   Simon Mark Director   –       •      –    2019-10-29 4 A $0.00 $0 D/D 18,144 18,144     -
   Deerfield Partners, Lp Possible Member of 10% Group   –       –       •   2019-10-29 4 B $11.00 $7,700,000 I/I 700,000 700,000 1.5     -
   Deerfield Partners, Lp Possible Member of 10% Group   –       –       •   2019-10-29 4 A $0.00 $0 I/I 928,506 464,253     -
   Green Jeremy 10% Owner   –       –       •   2019-10-29 4 A $0.00 $0 I/I 696,378 696,378     -
   Nichtberger Steven President & CEOOfficer   •       •      –    2019-10-24 3 IO $0.00 $0 I/I 0 363,000     -
   Nichtberger Steven President & CEOOfficer   •       •      –    2019-10-24 3 IO $0.00 $0 D/D 0 726,000     -

  40 Records found
  1  2    
  Page 2 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed